This is an open-label, dose escalation and expansion, multi-center phase 2 study evaluating the safety and efficacy of SR-8541A administered orally in combinat…

Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

~Estimated

~$10 – $8,750

Stingray TherapeuticsNCT06589440

Phase 1

A Phase I Dose-Escalation Trial of vvDD-hIL2-2-RG-1 (Vaccina Virus Double Deleted) Administered by Intra-tumoral (IT) Injection for Metastatic Gastrointestinal and Peritoneal Tumors

This research study aims to evaluate the safety and determine the optimal dose of a new experimental drug, vvDD-hIL2 (vaccinia virus double-deleted human inter…

Gastric NeoplasmsEsophageal CancerLiver Cancer+9 more

~Estimated

~$10 – $7,500

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT07001592